{"id":52842,"date":"2023-01-12T13:02:41","date_gmt":"2023-01-12T12:02:41","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/insights-on-the-2-8-billion-breast-biopsy-devices-global-market-to-2027-biopsy-forceps-segment-to-record-6-7-cagr-researchandmarkets-com\/"},"modified":"2023-01-12T13:02:41","modified_gmt":"2023-01-12T12:02:41","slug":"insights-on-the-2-8-billion-breast-biopsy-devices-global-market-to-2027-biopsy-forceps-segment-to-record-6-7-cagr-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/insights-on-the-2-8-billion-breast-biopsy-devices-global-market-to-2027-biopsy-forceps-segment-to-record-6-7-cagr-researchandmarkets-com\/","title":{"rendered":"Insights on the $2.8 Billion Breast Biopsy Devices Global Market to 2027 – Biopsy Forceps Segment to Record 6.7% CAGR – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Breast Biopsy Devices: Global Strategic Business Report”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global market for Breast Biopsy Devices estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$2.8 Billion by 2027, growing at a CAGR of 8.7% over the analysis period 2020-2027.\n<\/p>\n

\nBiopsy Guidance Systems, one of the segments analyzed in the report, is projected to record a 9.2% CAGR and reach US$1.1 Billion by the end of the analysis period.\n<\/p>\n

\nAfter an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Needle Based Biopsy Guns segment is readjusted to a revised 9.3% CAGR for the next 7-year period.\n<\/p>\n

\nThe U.S. Market is Estimated at $425 Million, While China is Forecast to Grow at 13.1% CAGR<\/strong>\n<\/p>\n

\nThe Breast Biopsy Devices market in the U.S. is estimated at US$425 Million in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$620.6 Million by the year 2027 trailing a CAGR of 13.1% over the analysis period 2020 to 2027.\n<\/p>\n

\nAmong the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.8% and 7.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.\n<\/p>\n

\nBiopsy Forceps Segment to Record 6.7% CAGR<\/strong>\n<\/p>\n

\nIn the global Biopsy Forceps segment, USA, Canada, Japan, China and Europe will drive the 6.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$70.4 Million in the year 2020 will reach a projected size of US$107.1 Million by the close of the analysis period.\n<\/p>\n

\nChina will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$383.4 Million by the year 2027, while Latin America will expand at a 8% CAGR through the analysis period.\n<\/p>\n

\nSelect Competitors (Total 23 Featured) –<\/strong>\n<\/p>\n